PubMed for id: 9214

Year	Number of Results
1992	1
1998	1
2002	1
2004	1
2005	1
2006	2
2007	2
2008	3
2009	3
2010	5
2011	7
2012	2
2015	1
2019	1
2020	3
2021	1
2023	2
2024	0

1

Mapping of the binding site for FcμR in human IgM-Fc.

Nyamboya RA, Sutton BJ, Calvert RA. Nyamboya RA, et al. Biochim Biophys Acta Proteins Proteom. 2020 Jan;1868(1):140266. doi: 10.1016/j.bbapap.2019.140266. Epub 2019 Aug 23. Biochim Biophys Acta Proteins Proteom. 2020. PMID: 31449905 Free PMC article.

2

Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells.

Murakami Y, Narayanan S, Su S, Childs R, Krzewski K, Borrego F, Weck J, Coligan JE. Murakami Y, et al. J Immunol. 2012 Jul 15;189(2):587-97. doi: 10.4049/jimmunol.1200840. Epub 2012 Jun 6. J Immunol. 2012. PMID: 22675200 Free PMC article.

3

TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.

Vire B, David A, Wiestner A. Vire B, et al. J Immunol. 2011 Oct 15;187(8):4040-50. doi: 10.4049/jimmunol.1100532. Epub 2011 Sep 9. J Immunol. 2011. PMID: 21908732 Free PMC article.

4

Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Li FJ, Kubagawa Y, McCollum MK, Wilson L, Motohashi T, Bertoli LF, Barton JC, Barnes S, Davis RS, Kubagawa H. Li FJ, et al. Blood. 2011 Nov 3;118(18):4902-9. doi: 10.1182/blood-2011-04-350793. Epub 2011 Sep 9. Blood. 2011. PMID: 21908424 Free PMC article.

5

[Expression and prognostic significance of TOSO in CD19+ B cells from Chinese CLL patients].

Yu Z, Zhou KS, Li ZJ, Yi SH, Hao M, Li CH, Qi JY, Qiu LG. Yu Z, et al. Zhonghua Yi Xue Za Zhi. 2011 May 31;91(20):1371-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756805 Chinese.

6

Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.

Hancer VS, Diz-Kucukkaya R, Aktan M. Hancer VS, et al. Med Oncol. 2012 Jun;29(2):1068-72. doi: 10.1007/s12032-011-9821-3. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264533

7

TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.

Yi S, Yu Z, Zhou K, Wang Y, An G, Li Z, Zou D, Qi J, Zhao Y, Chan WC, Qiu L. Yi S, et al. Leuk Lymphoma. 2011 Jan;52(1):72-8. doi: 10.3109/10428194.2010.531411. Epub 2010 Dec 6. Leuk Lymphoma. 2011. PMID: 21133733

8

Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, Gartland GL, Bertoli LF, Mori H, Takatsu H, Kitamura T, Ohno H, Wang JY. Kubagawa H, et al. J Exp Med. 2009 Nov 23;206(12):2779-93. doi: 10.1084/jem.20091107. Epub 2009 Oct 26. J Exp Med. 2009. PMID: 19858324 Free PMC article.

9

Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia.

Pallasch CP, Wendtner CM. Pallasch CP, et al. Leuk Lymphoma. 2009 Mar;50(3):498-501. doi: 10.1080/10428190902763491. Leuk Lymphoma. 2009. PMID: 19347734 Review.

10

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.

Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, Ultsch A, Wickenhauser C, Hallek M, Wendtner CM. Pallasch CP, et al. Blood. 2008 Nov 15;112(10):4213-9. doi: 10.1182/blood-2008-05-157255. Epub 2008 Aug 15. Blood. 2008. PMID: 18708628 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year